3+

population. The findings also support the program
of thyroxine replacement in the exposed Rongelap
population to prevent both clinical hypothyroidism andtheassociatedrise in plasma TSH, which
may be tumorigenic.

wassignificantly lower (6.0== 1.8 wg/dl). Thefrequencydistribution calculations (see Table 29 and
Figure 39) indicate that a substantial portion of
the Utirik population has plasma Ty concentration <3 ywg/dl. Measurements of plasma tn-

4. Thyroid Function in the Utirik and

tions in those patients with low Ty values. Plasma

Unexposed Rongelap Groups

iodothyronine (not shown) showedsimilar reduc-

During the 1973 survey, Ts and TSH concen-

40

trations were measured in plasma from 109 unexposed Rongelap and 97 exposed Utirik subjects

T

e---a Utirik

Rongelap group, 7.7 ug/dl, was the sameas in

the United States, and, as in the United States,
the plasma T, concentrations were skewed to the

Group
109 Rongelap
unexposed

97 Utirik
exposed

Subjects

4

T

Subjects

Plasma T,,
ue/dl

with value
<5.0.

with value
>113

7.7420

6%

6%

6.0% 1.8*

32%**

6%

2.5

“Significantly different, p<(0.001.

5.0

Rongelap

TBG-binding
capacity

n

pg T,/dl

TBG (RIA)
elo

yd7 Uli
/My

40;

TBG capacity
———

1
1

Rongelap

aap!!

4

I

Exposed

12

All sera
All sera*

25
22

Curik
All sera
All sera*

22
22

Unexposed

mg/dl

12.5

lap unexposed groups having given thyroxinelevels, 1973.

Thyroxine-Binding Globulin (TBG) Levels
(Mean = 5.D.) in Serum, 1973

n

10.0

Figure 39. Percentages of people in Utirik and in Ronge-

Table 30

Group

7.5

Plasma thyroxine (#g/ 100 mi)

**6% had values <3.8.

TBG by RIA

t

oa

ow

Plasma Thyroxine Concentrations (Mean = S.D.)
in Utirik and Unexposed Rongelap Populations,
March 1973

1

30
% oftotal population

Table 29

!

@o—e Rongelap
March 1973

(see Table 29). The mean Ty, in the unexposed

upper range. In the Utirik group, the mean T,

T

13

1.45240.54

14

21.54 69

1.64+0.95
1.3440.45

25°
21

23.14115
191+ 62

1.40+0.42
1.40+0.42

31
27)

189+ 78
16.4 43

1.8241.22

110

25.315.7

*Omitting sera with TBG >3 or TBG-binding capacity
>30.

Statistical comparisons revealed no significant difference ( p>0.05) between anyof the groups.

0

1

2

3 4 5

mg/dl

O

10 0 30

ug T2/dl

40 30

Figure 40. Thyroxine-binding globulin levels
in serum and TBG-binding capacity, 1973.

Select target paragraph3